… activation and denervation-induced skeletal muscle atrophy in the mouse model [55]. These
results indicate that ALKBH5 is a potential therapeutic target for neurogenic muscle atrophy. …

… In spite of many promising therapeutic targets for treating muscle wasting, not even a …
potential drugs (that are in use at laboratory/preclinical level of investigation using different atrophic …

… biological mechanisms that underlie muscle dysfunction and wasting in patients with COPD.
… of specific therapeutic targets that may alleviate muscle dysfunction and loss in patients with …

… on potential therapeutic strategies and mechanisms involved in muscle atrophy. … The
glucocorticoid-KLF15-BCAA pathway as a novel therapeutic target for muscular atrophy show us …

… of muscle atrophy. Here, we discuss how changes in muscle metabolism can be used as a
therapeutic target … exercise as tools for counteracting muscle wasting in atrophic conditions. …

The motor neuron degenerative disease spinal muscular atrophy (SMA) remains one of the
most frequently inherited causes of infant mortality. Afflicted patients loose the survival motor …

… loss and improves muscle strength. Thus the RAS is a promising target for the treatment of
muscle atrophy … article is part of a Directed Issue entitled: Molecular basis of muscle wasting. …

… muscle wasting and figure 1, there are several levels of possible therapeutic intervention to
limit muscle wasting… either promote muscle hypertrophy (such as insulin or IGF-1) [79], inhibit …

… maintaining skeletal muscle homeostasis, making it a potential therapeutic target for
improving skeletal muscle atrophy. Here, we review the pathogenesis of skeletal muscle atrophy, …

… key genes involved in muscle wasting in cachexia are associated … the potential role of miR-181
in regulating muscle wasting [13] . … dynamics and muscle wasting during ageing [19,20] . …